Related Experiment Video

Updated: Jul 11, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
11:17

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

Published on: January 7, 2016

Growth hormone therapy for short children born small for gestational age

P Chatelain1, A Carrascosa, G Bona

  • 1Service d'Endocrinologie et Diabétologie Pédiatrique, Hôpital Debrousse, Lyon, France. pierre.chatelain@chu-lyon.fr

Hormone Research
|September 8, 2007
PubMed

Insights

Children born small for gestational age often experience short stature due to growth hormone issues. Recombinant human growth hormone therapy can improve growth, with early, continuous treatment showing the best results.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Growth Disorders

Background:

  • Persistent short stature in children born small for gestational age (SGA) is a common concern.
  • Abnormal growth hormone (GH) secretion and insulin-like growth factor (IGF) levels are frequently associated with SGA-related growth retardation.
  • Current therapeutic options aim to address these hormonal imbalances to improve growth outcomes.

Purpose of the Study:

  • To review the efficacy and safety of recombinant human growth hormone (rhGH) treatment in children with persistent short stature.
  • To highlight key factors influencing treatment success, including timing, dosage, and duration.
  • To provide guidance on the clinical application of rhGH therapy for SGA-born children.

Main Methods:

  • Literature review of studies investigating rhGH therapy in SGA children.
  • Analysis of data on growth response, dose-dependency, and treatment continuity.
  • Examination of safety profiles and adverse events associated with rhGH use.

Main Results:

  • rhGH therapy can effectively improve growth velocity and final height in SGA children.
  • Early initiation of therapy demonstrates a more pronounced and sustained growth response.
  • Dose-dependent efficacy and the benefits of continuous treatment regimens are evident.
  • The safety profile of rhGH is generally favorable, with manageable side effects.

Conclusions:

  • rhGH is a valuable therapeutic option for managing persistent short stature in children born SGA.
  • Optimizing treatment by starting early, using appropriate doses, and ensuring continuous therapy maximizes benefits.
  • Careful monitoring for safety and efficacy is crucial for successful rhGH treatment outcomes.

More Related Videos

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...